NCT07099066Not yet recruiting
Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)
Generation of Skin Fibroblast Banks, Urine-derived Cells and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (Als)
Source: ClinicalTrials.gov · Last updated 1 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this research is to establish different cell banks from patients with amyotrophic lateral sclerosis (ALS).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 18 Jul 2025
- Start date
- 1 Sept 2025
- Primary completion date
- Apr 2026
- Lead sponsor
- Human Cell Design
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT07099066
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 Sept 2025 to the primary completion date, Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects who have undergone physical treatment (radiotherapy, etc.) on the area to be biopsied in the last 6 months;
Other illness
- Subjects with hereditary or acquired haemostasis disorders;
Lab values
- Subjects undergoing treatment likely to affect hemostasis (anticoagulants, platelet anti-aggregants, etc.) in the month prior to inclusion and during the study;
Age
- Subjects who have reached the age of majority and are subject to a protective measure or are unable to express their consent.
Other
- Subjects with contraindications to the collection of biological samples (blood, skin, urine).
- Lidocaine-intolerant subjects;
Who the study is looking for
- Subjects over 18 years old;
- Subjects who have given their consent and signed an informed, free and express consent form;
- Subjects with diagnosed ALS;
- Subjects affiliated to or benefiting from a social security scheme.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.